Abstract
In this study, we explored how patients experience current information provision and decision-making about post-treatment surveillance after breast cancer. Furthermore, we assessed patients' perspectives regarding less intensive surveillance in case of a low risk of recurrence. We conducted semi-structured interviews with 22 women in the post-treatment surveillance trajectory in seven Dutch teaching hospitals. Although the majority of participants indicated a desire for shared decision-making (SDM) about post-treatment surveillance, participants experienced no SDM. Information provision was often suboptimal and unstructured. Participants were open for using risk information in decision-making, but hesitant towards less intensive surveillance. Perceived advantages of less intensive surveillance were: less distressing moments, leaving the patient role behind, and lower burden. Disadvantages were: fewer moments for reassurance, fear of missing recurrences, and a higher threshold for aftercare for side effects. SDM about post-treatment surveillance is desirable. Although women are hesitant about less intensive surveillance, they are open to the use of personalised risk assessment for recurrences in decision-making about surveillance. To facilitate SDM about post-treatment surveillance, the timing and content of information provision should be improved. Risk information should be provided in an accessible and understandable way. Moreover, fear of cancer recurrence and other personal considerations should be addressed in the process of SDM.
Highlights
While the incidence of breast cancer is rising in the Netherlands, survival rates have improved due to early detection and improved treatment [1]
fear of cancer recurrence (FCR) should be addressed in decision-making about surveillance and in general, because research shows that women want to discuss FCR with their healthcare provider [19]
Fear of cancer recurrence and other personal considerations should be addressed in the process of shared decision-making (SDM)
Summary
While the incidence of breast cancer is rising in the Netherlands, survival rates have improved due to early detection and improved treatment [1]. These improvements have led to an increase in the prevalence and the number of breast cancer patients receiving follow-up care after curative treatment. Follow-up care can be subdivided into aftercare and post-treatment surveillance. Aftercare primarily focusses on information provision, guidance, identification and dealing with complaints, symptoms, and physical or psychosocial effects of the disease and treatment [2]. The primary aim of post-treatment surveillance is early detection of a locoregional recurrence or a second primary tumour [2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.